Qaybaha borotiinka ku xidhan ee Sirolimus ayaa loo oggolaaday buro unugga unugyada epithelioid perivascular malignant

La qaybso Post this

Janaayo 2022: Bukaannada qaangaarka ah ee leh burooyinka unugga unugyada epithelioid ee xuubka xuubka xididdada dhiigga ee aan la sixin karin ama metastatic, Maamulka Cuntada iyo Dawooyinka ayaa shati u haysta Qaybaha borotiinka ku xidhan sirolimus ee ka joojinta la isku duro (albumin-ku xidhan) (Fyarro, Aadi Bioscience, Inc.) (PEComa).

Efficacy was tested in 31 patients with locally advanced unresectable or metastatic malignant PEComa in AMPECT (NCT02494570), a multicenter, single-arm clinical study. On days 1 and 8 of each 21-day cycle, patients received 100 mg/m2 sirolimus protein-bound particles until disease progression or intolerable toxicity.

Heerka jawaabta guud (ORR) iyo muddada jawaabta (DOR) waxay ahaayeen cabbirada natiijooyinka waxtarka ee muhiimka ah, sida lagu go'aamiyay dib-u-eegis madax-bannaan oo madax-bannaan oo indha la' iyadoo la adeegsanayo RECIST v.1.1. ORR wuxuu ahaa 39 boqolkiiba (95 boqolkiiba CI: 22 boqolkiiba, 58 boqolkiiba), iyadoo laba bukaan ay si buuxda uga jawaabeen. Dhexdhexaadka DOR lama buuxin (95 boqolkiiba CI: 6.5 bilood, lama qiyaasi karo). 67 boqolkiiba jawaab bixiyaasha ayaa helay jawaab socotay in ka badan 12 bilood, iyo 58 boqolkiiba waxay heleen jawaab socotay in ka badan 24 bilood.

Stomatitis, daal, finan, caabuq, lallabbo, edoema, shuban, raaxo la'aanta muruqyada, miisaanka oo yaraada, rabitaanka cuntada oo yaraada, qufaca, matagga, iyo dysgeusia ayaa ahaa dhacdooyinka ugu badan ee dhinaca (boqolkiiba 30). Limfosaytis hoos u dhaca, gulukoosta oo kordha, potassium hoos u dhaca, fosfooraska hoos u dhaca, hoos u dhaca haemoglobin, iyo lipase sare ayaa ah kuwa ugu badan ee aan caadiga ahayn ee shaybaadhka 3 ilaa 4 (6%).

Ilaa uu cudurku ka sii socdo ama sunta aan loo dulqaadan karin, qiyaasta lagu taliyey waa 100 mg/m2 la siiyay faleebo IV ah 30 daqiiqo maalmaha 1 iyo 8 ee wareeg kasta oo 21-maalmood ah.

 

Click this link for full prescribing information for Fyarro.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha
Daaweynta T-Cell-ka Baabuurka

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha

Daawaynta Unugyada CAR-ku-salaysan ee bini-aadmigu waxa ay wax ka beddeshaa daawaynta kansarka iyada oo hidde ahaan wax ka beddeleysa unugyada difaaca bukaanka si ay u beegsato oo ay u burburiso unugyada kansarka. Ka faa'iidaysiga awoodda habka difaaca jidhka, daawayntani waxay bixiyaan daweyn awood leh oo shakhsi ahaaneed oo leh suurtagalnimada cafis waara ee noocyada kala duwan ee kansarka.

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta
Daaweynta T-Cell-ka Baabuurka

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta

Cytokine Release Syndrome (CRS) waa falcelin habdhiska difaaca oo inta badan ka dhasha daawaynta qaarkood sida immunotherapy ama daawaynta unugga CAR-T. Waxay ku lug leedahay sii-deynta xad-dhaafka ah ee cytokines, taasoo keenta calaamado u dhexeeya qandho iyo daal ilaa dhibaatooyin nafta halis gelin kara sida dhaawaca xubnaha. Maareyntu waxay u baahan tahay kormeer taxadar leh iyo xeelado faragelineed.

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton